Literature DB >> 15582222

Protein quality control in Alzheimer's disease by the ubiquitin proteasome system.

F M S de Vrij1, D F Fischer, F W van Leeuwen, E M Hol.   

Abstract

The ubiquitin proteasome system (UPS) is the major protein quality control system in eukaryotic cells. Many neurodegenerative diseases are characterized by aggregates and inclusions of aberrant proteins, implying a sub-optimal functioning or defective UPS. The last few years have seen increasing evidence for the involvement of the UPS in neurodegenerative disorders, including Alzheimer's disease (AD). Notably, decreases in proteasome activity were detected in several cortical areas in AD patients. In addition, proteins that accumulate in the classical hallmarks of AD were linked to UPS function. This review specifically discusses the involvement of the UPS in AD pathogenesis. First, a detailed overview of the UPS is presented, after which AD pathology and its relation to the UPS is discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15582222     DOI: 10.1016/j.pneurobio.2004.10.001

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  49 in total

1.  Abeta-mediated NMDA receptor endocytosis in Alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61.

Authors:  Pradeep Kurup; Yongfang Zhang; Jian Xu; Deepa V Venkitaramani; Vahram Haroutunian; Paul Greengard; Angus C Nairn; Paul J Lombroso
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

Review 2.  Neuronutrition and Alzheimer's disease.

Authors:  Balenahalli N Ramesh; T S Sathyanarayana Rao; Annamalai Prakasam; Kumar Sambamurti; K S Jagannatha Rao
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 3.  The ubiquitin-proteasome pathway and synaptic plasticity.

Authors:  Ashok N Hegde
Journal:  Learn Mem       Date:  2010-06-21       Impact factor: 2.460

4.  Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population.

Authors:  Christine C Tangney; Mary J Kwasny; Hong Li; Robert S Wilson; Denis A Evans; Martha Clare Morris
Journal:  Am J Clin Nutr       Date:  2010-12-22       Impact factor: 7.045

Review 5.  Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions.

Authors:  Masashi Kitazawa; Rodrigo Medeiros; Frank M Laferla
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 6.  Cell cycle molecules define a pathway required for neuron death in development and disease.

Authors:  Lloyd A Greene; David X Liu; Carol M Troy; Subhas C Biswas
Journal:  Biochim Biophys Acta       Date:  2006-12-13

7.  Intermediate filament transcription in astrocytes is repressed by proteasome inhibition.

Authors:  Jinte Middeldorp; Willem Kamphuis; Jacqueline A Sluijs; Dalila Achoui; Cathalijn H C Leenaars; Matthijs G P Feenstra; Paula van Tijn; David F Fischer; Celia Berkers; Huib Ovaa; Roy A Quinlan; Elly M Hol
Journal:  FASEB J       Date:  2009-03-30       Impact factor: 5.191

8.  Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model.

Authors:  Saravanan S Karuppagounder; Hui Xu; Qingli Shi; Lian H Chen; Steve Pedrini; David Pechman; Harriet Baker; M Flint Beal; Sam E Gandy; Gary E Gibson
Journal:  Neurobiol Aging       Date:  2008-04-10       Impact factor: 4.673

9.  UCH-L1 inhibition involved in CREB dephosphorylation in hippocampal slices.

Authors:  Min Xie; Shao-Hui Wang; Zhi-Min Lu; Ying Pan; Qi-Cai Chen; Xiao-Mei Liao
Journal:  J Mol Neurosci       Date:  2013-12-10       Impact factor: 3.444

10.  Proteomic analysis of protein phosphorylation and ubiquitination in Alzheimer's disease.

Authors:  Stefani N Thomas; Diane Cripps; Austin J Yang
Journal:  Methods Mol Biol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.